TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice

Neutralization of tumor necrosis factor (TNF) represents a widely used therapeutic strategy for autoimmune diseases including inflammatory bowel disease (IBD). However, the fact that many patients with IBD are non-responsive to anti-TNF therapies suggests the need for a better understanding of TNF s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cambrian Y., Tam, Sharon S., Huang, Ying, Dubé, Philip E., Alhosh, Rabea, Girish, Nandini, Punit, Shivesh, Nataneli, Shirin, Li, Fan, Bender, Jeffrey M., Washington, M. Kay, Polk, D. Brent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682618/
https://www.ncbi.nlm.nih.gov/pubmed/33086075
http://dx.doi.org/10.1016/j.celrep.2020.108275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682618/
https://www.ncbi.nlm.nih.gov/pubmed/33086075
http://dx.doi.org/10.1016/j.celrep.2020.108275

Ejemplares similares